Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Sympathetic Paraganglioma — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Endocrine Neoplasm
Neuroendocrine Neoplasm
Paraganglioma
Sympathetic Paraganglioma

Subtype

Sympathetic Paraganglioma

CI-CAN-00004047Explore in graph →

Non-malignant27 active trials2 evidence items

NCIt: C4216

Overview
Statistics
Survival
Genomics
Variants & evidence2
Drugs
Trials127
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

127 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

StatusAll Active (any)Completed 48 Recruiting 23 Unknown 14 Active Not Recruiting 10 Terminated 10 Not Yet Recruiting 8 Withdrawn 5 No Longer Available 3 Available 3 Approved For Marketing 2 Enrolling By Invitation 1

PhaseAll Early Phase 1 3 N/A 11 Phase 1 16 Phase 2 45 Phase 3 5 Phase 4 3

No study matches these filters